Found 0 matching trials
Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients
N/AThe NeuMoDx EBV Quant Assay 2.0 study is a multi-center, observational clin...
Location
QIAGEN Gaithersburg, Inc.
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL
PHASE3This is a randomized, open-label, prospective, multicenter phase III superi...
Location
Fudan University Shanghai Cancer Center,
Plasma EBV DNA Monitoring in Post-treatment NPC Patients
N/AContinuous regular monitoring of plasma EBV DNA in nasopharyngeal carcinoma...
Location
Taichung Veterans General Hospital
Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA
PHASE2This is a single-arm, multi-center, open-label, phase II trial to examine t...
Location
Changhua Christian Hospital
Serial Plasma EBV DNA for Nasopharyngeal Carcinoma
N/ANasopharyngeal carcinoma (NPC) is an endemic malignancy in Southern China, ...
Location
Department of Clinical Oncology, Queen Mary Hospital
Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC
PHASE3This Phase III multicenter trial investigates treatment intensification for...
Status
Active Not Recruiting
Location
Chongqing University Cancer Hospital
Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases
N/AThis study is a single-center, prospective, observational clinical study to...
Location
Beijing Friendship Hospital, Capital Medical University
Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma Patients
N/AEndemic nasopharyngeal carcinoma (NPC) is invariably associated with Epstei...
Location
Sun Yat-sen University Cancer Center
Donor-Derived Viral Specific T-cells (VSTs)
PHASE1In this research study, the investigators want to learn more about the use ...
Location
Akron Children's Hospital
Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE2This is a Phase II trial to study the effectiveness of two cycles versus th...
Location
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center